Tradestie Institutional Equity Comparison Engine

NHP vs HR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HR Overall Edge

HR Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Healthcare Realty Trust Incorporated (HR) driven by superior Valuation, Growth & Margin while NHP counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, NHP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HR at 10.8x Forward P/E and 13.2% operating margin (-3.6% YoY). In options structure, NHP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HR sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HR
NHP N/M vs HR 10.8x Fwd P/E
Growth & Margin Winner HR
Op Margin N/A vs 13.2% ยท YoY N/A vs -3.6%
Momentum & Technical Winner NHP
1Y +23.5% vs +8.3% ยท 52W Pos 58% vs 53%
Options & Structure Winner NHP
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (9th %ile IV)
NHP US Equity
NHP
Institutional Equity
$14.82
+2.14% 1D
Market Cap N/A
1M Return -6.2%
1Y Return +23.5%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 64.0 Fund 51.0 Flow 50.0 Mom 60.0
HR NYSE
Healthcare Realty Trust Incorporated
Real Estate Investment Trusts
$19.36
+0.0% 1D
Market Cap $6.7B
1M Return +7.98%
1Y Return +8.28%
Forward P/E 10.8x
Unified AI Score
48.3 / 100 HOLD
Tech 33.0 Fund 44.0 Flow 48.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NHP +23.5% HR +8.28% Spread: +17.77 pp (NHP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NHP TTM Op. Margin: N/A HR TTM Op. Margin: 13.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NHP vs HR. Trailing 12-month operating profitability (NHP N/A vs HR 13.2%) and valuation multiples (NHP N/M vs HR 10.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NHP (2) vs HR (8)
Institutional Metric NHP HR Criterion Row Winner
Market Capitalization Scale N/A $6.7B Larger Scale HR
Trailing P/E Ratio Valuation N/M 10.8x Lower Multiple HR
Forward P/E Ratio Valuation N/M 10.8x Lower Multiple HR
Revenue Growth (YoY) Growth N/A -3.6% Higher Growth HR
Operating Margin (TTM) Profitability N/A 13.2% Higher Margin HR
Net Profit Margin Profitability N/A -4.0% Higher Margin HR
Return on Equity (ROE) Capital Efficiency N/A -1.0% Higher ROE HR
52-Week Range Position Momentum 58% ($11โ€“$17) 53% ($16โ€“$22) Stronger Trend NHP
Beta / 30D Volatility Risk Regime 0.20ฮฒ ยท 34% Vol 0.08ฮฒ ยท 21% Vol Lower Realized Risk HR
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite NHP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NHP vs HR Buy Guide
NHP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NHP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HR CONSOLIDATION
112d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live HR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NHP nor HR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.